PTX3 as a potential biomarker of acute lung injury: supporting evidence from animal experimentation
- 18 November 2009
- journal article
- research article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 36 (2) , 356-364
Abstract
Increased expression of long pentraxin 3 (PTX3) has been found in patients with sepsis or acute respiratory distress syndrome. Tissue factor (TF) activation plays an important role in the pathogenesis of acute lung injury. The present study sought to determine the relationship between PTX3 expression and TF activation in acute lung injury.Keywords
This publication has 37 references indexed in Scilit:
- Biomarkers in acute lung injury: Are we making progress?*Critical Care Medicine, 2008
- Intra-alveolar tissue factor pathway inhibitor is not sufficient to block tissue factor procoagulant activityAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention?British Journal of Pharmacology, 2008
- Expression of human tissue factor under the control of the mouse tissue factor promoter mediates normal hemostasis in knock-in miceJournal of Thrombosis and Haemostasis, 2008
- INTESTINAL ISCHEMIA-REPERFUSION-INDUCED ACUTE LUNG INJURY AND ONCOTIC CELL DEATH IN MULTIPLE ORGANSShock, 2007
- Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associationsTranslational Research, 2007
- The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factorThorax, 2007
- The Role of the Coagulation Cascade in the Continuum of Sepsis and Acute Lung Injury and Acute Respiratory Distress SyndromeSeminars in Respiratory and Critical Care Medicine, 2006
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001
- The Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000